Jacobus Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,655
Closed -$167K 272
2015
Q4
$167K Sell
1,655
-100
-6% -$10.4K 0.05% 219
2015
Q3
$172K Buy
1,755
+670
+62% +$74.4K 0.05% 220
2015
Q2
$127K Sell
1,085
-629
-37% -$68.7K 0.03% 270
2015
Q1
$168K Hold
1,714
0.04% 231
2014
Q4
$162K Hold
1,714
0.04% 226
2014
Q3
$182K Sell
1,714
-682
-28% -$66.8K 0.05% 215
2014
Q2
$199K Sell
2,396
-185
-7% -$14.4K 0.05% 209
2014
Q1
$183K Buy
2,581
+304
+13% +$23.8K 0.04% 224
2013
Q4
$171K Sell
2,277
-50
-2% -$3.48K 0.05% 226
2013
Q3
$146K Sell
2,327
-100
-4% -$5.98K 0.05% 205
2013
Q2
$124K Buy
+2,427
New +$127K 0.05% 206

Other funds holding GILD

Jacobus Wealth Management's GILD Position: Q1 2016 in Review

Jacobus Wealth Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 1,655 shares — an estimated $167K sold.

Jacobus Wealth Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $199K in Q2 2014. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Jacobus Wealth Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Jacobus Wealth Management sold 1,655 Gilead Sciences shares in Q1 2016, an estimated $167K.
  • Jacobus Wealth Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Jacobus Wealth Management's Gilead Sciences position peaked at $199K in Q2 2014.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Jacobus Wealth Management's 13F filing for Q1 2016, filed 23 May 2016.